At Boston Interactome, we’re pioneering a breakthrough in biotechnology by precision mapping the human protein interactome to develop next-generation therapies. Our goal is to eliminate drug side effects entirely and usher in a new era of safer, more targeted treatments.
We’re targeting neuropsychiatric disorders, in particular schizophrenia and addiction. The unmet need is significant - millions of patients are suffering from these conditions but no therapeutic options exist that address the drivers of disease.
We aim to change that. These disorders are characterized by aberrant PPIs in a class of multisubunit protein complexes known as epigenetic protein complexes. Their dysregulation leads to the long-term neuronal plasticity underpinning these disorders. Our platform lets us target this class of proteins for the first time. Previous efforts that targeted whole epigenetic proteins showed therapeutic efficacy - but unacceptable safety profiles. That is why we think we can win: these targets are only accessible to the PPI approach.
Company Details
- Employees
- 2
- Founded
- -
- Address
- 241 Francis Ave, Mansfield,massachusetts 02048,united States
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Keywords
- Protein-protein interactions, Neuropsychiatric disorders, Schizophrenia, Addiction, Substance use disorder, Opioid use disorder, Schizoaffective disorder, PPIs, Drug discovery, Biotechnology, Platform, CNS diseases, Neuroscience, Therapeutics, Drug development, Epigenetics.
- HQ
- Mansfield, Massachusetts
Boston Interactome Questions
Boston Interactome's LinkedIn profile is https://www.linkedin.com/company/boston-interactome
Boston Interactome has
2 employees.
View email and phone details for 2
employees at Boston Interactome.
Boston Interactome's industry is
Biotechnology Research
Boston Interactome's top competitors are
Solt Db,
Coord Health,
Valo Health,
Adeno, Inc.,
Scisynopsis Conferences,
Grow By Ginkgo,
Eqbridge,
Tritica Biosciences,
Gofigr.io,
Ampseq.
Boston Interactome's categories are Biotechnology Research
Boston Interactome's founding year is 2024
